Portal de investigación
A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
PRINCESS MÁXIMA CENTER FOR PEDIATRIC ONCOLOGY B.V.,
Cita
A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML. (ITCC-101/APAL2020D). PRINCESS MÁXIMA CENTER FOR PEDIATRIC ONCOLOGY B.V.,. 2023IP:JOSÉ MARÍA FERNÁNDEZ NAVARRO.